Previous close | 6.38 |
Open | 6.33 |
Bid | 5.95 x 600 |
Ask | 6.00 x 100 |
Day's range | 5.90 - 6.33 |
52-week range | 5.84 - 21.42 |
Volume | |
Avg. volume | 1,380,196 |
Market cap | 502.114M |
Beta (5Y monthly) | 1.94 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Verve Therapeutics, Inc. ( NASDAQ:VERV ) just released its first-quarter report and things are looking bullish. Results...
Verve Therapeutics, Inc. ( NASDAQ:VERV ) shareholders will have a reason to smile today, with the analysts making...
Verve Therapeutics ( NASDAQ:VERV ) First Quarter 2024 Results Key Financial Results Revenue: US$5.70m (up 306% from 1Q...